Health Condition 1: null- All fullterm pregnant patients having live singleton fetus with vertex presentation and Bishops less than score 5.
Conditions
Interventions
Intervention1: Tab misoprostol: 25mcg oral 4 hourly max 5 doses .
Control Intervention1: Tab Misoprostol/cipla ltd.: 25 mcg per vaginal 4 hourly max 5 doses.
Sponsors
AGMC and GBP Hospital Agartala
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. A live singleton pregnancy of > 37 weeks for obstetric or medical indication for induction 2. Vertex presentation. 3. Prolonged pregnancy. 4. Bishop score less than 5. 5. Intact membrane without previous stripping.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Suspected cephalo-pelvic disproportion. 2. Previous caesarean section or history of uterine surgery. 3. Multiple gestations. 4. Malpresentation. 5. Any contraindication for vaginal delivery or prostaglandin administration and suspected chorioamnionitis. 6. Suspected fetal jeopardy. 7. Placenta previa. 8. Grand multigravida.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time interval from induction to vaginal delivery.Timepoint: The time interval from induction to vaginal delivery. | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Rate of vaginal delivery within 24 hours. â?¢ Caesarian section rate. â?¢ Uterine tachysystole. â?¢ Neonatal outcome. Timepoint: till 18 hours after the last dose administered. | — |
Countries
India
Contacts
Public ContactApratim Mohan DebBarma
AGMC and GBP Hospital
Outcome results
None listed